Costa Rica a Hotspot for Medical Devices Sector Investments

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Prominent life sciences companies are investing the medical devices sector in Costa Rica.

Six out of the 10 world's major pharmaceutical companies within this sector have manufacturing operations in the Central American country.

Costa Rica aims at becoming one of the leading life science hubs in the region and has seven free trade zones to host this type of specialized production and skilled workforce. Companies such as Abbott Laboratories (NYSE:ABT) (Chicago, Illinois), Boston Scientific (NYSE:BSX) (Marlborough, Massachusetts), Viant Medical (Foxborough, Massachusetts), Bayer (Leverkusen, Germany), MicroVention Incorporated (Aliso Viejo, California) and Medtronic plc (NYSE:MDT) (Minneapolis, Minnesota) are investing in the country.

Industrial Info is currently tracking 32 capital-spending projects in the medical devices sector in Costa Rica, totaling US$725 million in value. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for the list of projects.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).